Jump to content

Celiac.com Sponsor (A1):

Celiac.com Sponsor (A1-m):

  • You've found your Celiac Tribe! Join our like-minded, private community and share your story, get encouragement and connect with others.


    • Sign In
    • Sign Up
  • Scott Adams
    Scott Adams

    Can Rapid Finger Prick Antibody Tests Improve Screening for Celiac Disease in Children?

    Reviewed and edited by a celiac disease expert.

    Based on these results, current POC tests were not useful in screening for celiac disease in the general population of first-grade schoolchildren. 

    Can Rapid Finger Prick Antibody Tests Improve Screening for Celiac Disease in Children? - Finger stick tests may not work to diagnose CD. Image: CC BY 2.0--osseous
    Caption: Finger stick tests may not work to diagnose CD. Image: CC BY 2.0--osseous

    Celiac.com 04/06/2020 - Celiac disease is an autoimmune disease driven by exposure to gluten in  people who carry certain genes. Despite better awareness, easier testing, and rising rates of celiac disease, many patients remain undiagnosed. The expense, inconvenience, and invasiveness of standardization blood tests has led to the development of several point-of-care tests (POC) for celiac disease. A team of researchers recently set out to assess celiac disease rates in first-grade pupils in Primorje-Gorski Kotar County, Croatia, using a POC test. 

    The research team included Kristina Baraba Dekanić, Ivona Butorac Ahel, Lucija Ružman, Jasmina Dolinšek, Jernej Dolinšek, and Goran Palčevski. They are variously affiliated with the Department of Pediatrics, University Hospital Center Rijeka, Istarska 43, 51 000 Rijeka, Croatia; the Office of Project Development-Project Office, Municipality of Maribor, Ulica Heroja Staneta 1, Slovenia; and the Department of Pediatrics, University Medical Center Maribor, Ljubljanska 5, 2 000 Maribor, Slovenia.

    Celiac.com Sponsor (A12):

    Celiac.com Sponsor (A12-m):

    The team used a Biocard celiac test that detects IgA antibodies to tissue transglutaminase in whole blood on a group of healthy first-grade children born in 2011 and 2012 who freely consumed dietary gluten. 

    In all, the team tested 1,478 children, none of whom tested positive with a rapid test. Researchers suspected IgA deficiency in ten children, only four of whom agreed to be tested further for total IgA, anti-tTG, and anti-DGP antibodies. 

    Those further tests confirmed IgA deficiency in three patients, while celiac disease was excluded in all four children. 

    Based on these results, current POC tests were not useful in screening for celiac disease in the general population of first-grade schoolchildren. 

    The team notes that more research is needed to catch all cases of celiac disease in Primorje-Gorski Kotar County, and to establish the usefulness of rapid celiac testing against standard celiac antibody testing. 

    So, don't look to finger-prick tests or other point-of-care tests to revolutionize celiac diagnosis, at least in the short to near-term. 

    Read more in Gastroenterology Research and Practice / 2019

    Edited by Scott Adams

    User Feedback

    Recommended Comments

    There are no comments to display.

    Join the conversation

    You are posting as a guest. If you have an account, sign in now to post with your account.
    Note: Your post will require moderator approval before it will be visible.

    Add a comment...

    ×   Pasted as rich text.   Restore formatting

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.

  • About Me

    Scott Adams

    Scott Adams was diagnosed with celiac disease in 1994, and, due to the nearly total lack of information available at that time, was forced to become an expert on the disease in order to recover. In 1995 he launched the site that later became Celiac.com to help as many people as possible with celiac disease get diagnosed so they can begin to live happy, healthy gluten-free lives.  He is co-author of the book Cereal Killers, and founder and publisher of the (formerly paper) newsletter Journal of Gluten Sensitivity. In 1998 he founded The Gluten-Free Mall which he sold in 2014. Celiac.com does not sell any products, and is 100% advertiser supported.

  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):

    Celiac.com Sponsors (A17-m):

  • Related Articles

    Jefferson Adams
    Celiac.com 10/23/2013 - Celiac disease remains seriously under diagnosed in adults and, in many places, often takes years and even decades to diagnose.
    A team of researchers recently evaluated the usefulness of an on-site rapid fingertip whole blood point-of-care test (POCT) that would help primary workers to spot patients who might benefit from further diagnostic tests for celiac disease.
    The research team included Alina Popp, Mariana Jinga, Ciprian Jurcut, Vasile Balaban, Catalina Bardas, Kaija Laurila, Florina Vasilescu, Adina Ene, Ioana Anca and Markku Mäki. They are affiliated with the University of Medicine and Pharmacy “Carol Davila,” the Institute for Mother and Child Care “Alfred Rusescu,” Central University Emergency Military Hospital “Dr. Carol Davila,” Str. Mircea Vulcanescu, in Bucharest, Romania and with theTampere Center for Child Health Research, University of Tampere and Tampere University Hospital, in Tampere, Finland.
    Because celiac disease often runs in families, the team tested 148 healthy relatives of 70 Romanian index cases with biopsy-proven celiac disease, for a total of 87% of all first-degree family members, with a median age 36 years, for the presence of circulating autoantibodies.
    In addition to using the POCT to measures blood erythrocyte self-TG2-autoantibody complexes on site, the team took blood samples for later evaluation of serum IgA-class endomysial antibodies (EMA).
    The then tested all EMA-positive samples for transglutaminase 2 antibodies (TG2-IgA). They conducted blind analysis of all serological parameters in a centralized laboratory with no knowledge of the on site POCT result. The team recommended endoscopic small intestinal biopsies for all POCT- or EMA-test positive subjects.
    Overall, 12 of 148 (8%) first-degree relatives showed positive results for the POCT, and all twelve tested serum EMA-positive. Only one other test subject showed a positive EMA test result.
    All remaining 135 healthy first-degree relatives showed negative results for both POCT and EMA.
    Four subjects who tested positive for both POCT and EMA were negative for TG2-IgA. Ten out of thirteen of the antibody-positive subjects consented to endoscopy.
    In all, eight out of nine first-degree relatives with celiac-type mucosal lesions of grade Marsh 2 (n = 3) or Marsh 3 (n = 6) showed positive results with the POCT.
    The three POCT-positive subjects refused endoscopy tested positive for both EMA and TG2-IgA.
    The fingertip whole blood rapid POCT could be a simple and cheap way to spot biomarkers and promote further testing for faster diagnosis of celiac disease.
    The team is calling for further studies in adult case-finding in specialized outpatient clinics and in primary care.
    BMC Gastroenterology 2013, 13:115. doi:10.1186/1471-230X-13-115

    Vanessa Maltin Weisbrod
    Celiac.com 11/11/2017 - (NOTE: This article is from 2012 and is being made available as Celiac.com rolls our past issues of Journal of Gluten Sensitivity) It's just like being a little kid with a super sore throat and your mom taking you to the doctor to get a test for strep throat. The doctor swabs your throat with two sticks to find out what nasty bacteria is camping out. In just moments you've got a diagnosis of strep throat and can start antibiotics to miraculously make the pain go away. You go home with a prescription, get in bed and eat mom's homemade chicken rice soup until you feel better in a couple of days. How cool would it be if getting diagnosed with celiac disease was this easy?
    The wonderful news is that we're getting closer to having a test that will diagnose celiac disease with just a simple prick of a finger and a 10-minute wait. The CeliacSure Test Kit measures (anti-tTG) IGA antibodies from a fingertip blood sample. It works by taking a small drop of blood, mixing it with a buffer and applying the mixture onto a test cartridge. Within moments two red lines appear if the test is positive, while only one line appears if the result is negative. And, you can take the test at home without ever getting out of your pajamas!
    "The test kit is a point-of-care, at-home test that's very similar to reading results of a pregnancy test," said Dr. Daniel Leffler of the Celiac Disease Center at Beth Israel Deaconess Medical Center in Boston. Dr. Leffler, a gastroenterologist by training with a background in nutrition, has a long-standing interest in celiac disease. Several years ago he teamed up with Dr. Ciaran Kelly and Dietitian Melinda Dennis to found the Celiac Disease Center at Beth Israel Deaconess Medical Center where they focus not only on providing top notch patient care, but also on high level disease research. The latest project: studying the efficacy of the CeliacSure test for celiac disease diagnosis.
    Dr. Leffler said his team got involved with the finger prick test study because they feel it's important to take down barriers to patients getting diagnosed with celiac disease. "We do a lot with educating other medical providers about offering in-clinic testing, but I think it's really important to put a tool in the hands of the people."
    "We've teamed up with the [marketers] of the test kit at GlutenPro/Biocard CeliacSure Test to see how effective this test is in the USA. We're providing 2 kits per family to use on first-degree relatives of people with celiac disease. To qualify, participants in the study must not be on a gluten-free diet. We send them the test kit to take as well as a survey about their ability to use and understand the test. The goal is that this small study comes out favorable [sic] so we can move on to large scale studies that will compare the finger prick test to the gold standard laboratory serology testing."
    Dr. Leffler says he's really excited about the potential of this point-of-care test because it will "allow us to reach a population that might not otherwise come in to get tested, mainly first degree relatives of patients already diagnosed with celiac disease."
    It's important to note that right now the CeliacSure test is only for research purposes, not actual diagnosis. It is available in Canada and other countries, but it's still under evaluation here in the United States. And, while the strep throat analogy is a great way to think about how this test will work, it's extremely important to understand that if you get a positive result with the CeliacSure test, do not start a gluten-free diet until you have followed up with a doctor to confirm the diagnosis.
    As with all medical studies there's some fine print you need to know about. Participants in the study must meet all of the following criteria:
    1. Over the age of 18
    2. A first or second degree relative with celiac disease
    3. Not previously diagnosed with celiac disease
    4. Not on a gluten-free diet or low-gluten diet within the past 3 months
    5. Able and willing to self administer the test, complete a short survey form and return both in the envelope provided
    6. Willingness to have follow up medical evaluation in the event of a positive test
    7. A resident of the United States
    Listen to a full interview with Dr. Leffler about the CeliacSure study on the Hold the Gluten Podcast (http://traffic.libsyn.com/holdthegluten/050_HoldTheGluten-05Apr2012.mp3) with Vanessa Maltin Weisbrod and Maureen Stanley now! And, if you would like to participate in the study, please contact Dr. Toufic Kabbani at celiac@bidmc.harvard.edu or by phone at 617-667-0528.

    Jefferson Adams
    Celiac.com 01/29/2019 - Serology-based criteria for adult celiac disease have excellent pre-test accuracy, but can they be helpful in spotting celiac disease without biopsy? New criteria for diagnosing celiac disease in children allow doctors to forgo duodenal biopsies in children who have symptoms, positive blood tests, and celiac disease-associated genes. However, there’s currently no good data on whether such an approach might work for adults with certain clinical presentations of celiac disease.
    A team of researchers recently set out to evaluate the accuracy of serology-based criteria in adults with variable pre-test probabilities for celiac disease.
    The Finnish research team included V Fuchs, K Kurppa, H Huhtala, K Laurila, M Mäki, P Collin, T Salmi, L Luostarinen, P Saavalainen, and K Kaukinen. 
    The team compiled three study groups, including 421 adults with high-risk clinical celiac disease suspicion, 2,357 moderate-risk family members of celiac patients, and 2,722 low-risk individuals from the general population. 
    They collected blood tests and other physical patient data. Their "triple criteria" for celiac disease included transglutaminase 2 antibodies more than ten times the upper limit of normal, positive endomysium antibodies, and appropriate genetics, but required no symptoms. The diagnosis was made by grading the intestinal biopsies.
    Can a Biopsy be Avoided when Diagnosing Celiac Disease?
    In all, 274 patients were diagnosed with celiac disease. Of these, 59 high-risk subjects, 17 moderate-risk subjects, and 14 low-risk subjects fulfilled the "triple criteria.” 
    All had histologically proven celiac disease, giving the criteria a positive predictive value of 100%. Altogether, 90 of the 274 newly diagnosed patients could have avoided biopsy. That’s one in three patients who could have avoided biopsy. In all, 37% of high-risk, 20% of moderate-risk, and 48% of low-risk patients could have avoided biopsy. 
    Biopsies of "triple positive" subjects showed no histological findings other than celiac disease. The results of this study are exciting, because they show that the “triple criteria” can be used by doctors to reliably spot celiac disease in adults without using biopsy. 
    Implementing these diagnostic criteria would make diagnosing celiac disease easier in many cases, and will reduce the number of endoscopies by one-third. That’s a winning result all the way around.
    Read more at: Aliment Pharmacol Ther. 2018 Dec 27. doi: 10.1111/apt.15109.

    Jefferson Adams
    Celiac.com 07/18/2019 - Autoimmune conditions cause the body to attack its own healthy cells. There are nearly one-hundred known autoimmune conditions, including lupus, celiac disease, and rheumatoid arthritis.
    Diagnosing autoimmune conditions can sometimes be difficult, so any progress toward faster, cheaper, or more reliable testing methods could play a significant role in improving diagnosis and reducing time to treatment. Approval by the FDA is key to making such tests available commercially.
    A New York startup company, Aesku.NY, has received FDA approval for tests to detect two of those autoimmune diseases, with tests for other diseases expected to follow. 
    The approved tests for celiac disease, and the connective tissue disorder, lupus, would still require patients who screen positive to receive further testing for a specific diagnosis.
    However, the tests are designed to be cost effective, and efficient, potentially increasing the availability of a reliable screening method for diseases that are best caught and treated early.
    "In many autoimmune diseases, if you don't have a good test, it takes many years to pinpoint a diagnosis," says company founder Dr. Vijay Kumar. "Again, coming back to celiac disease, it used to be 3-5 years before a diagnosis is made," he added, "[t]hink about how many physicians, clinicians, laboratories, the patient might have gone through."
    Aesku.NY tests are produced domestically, in Buffalo New York.
    Stay tuned for more news on developments in celiac disease diagnostics, and related topics.

    Listen to WBFO's Mike Desmond

  • Popular Now

  • Create New...